Pharmacologic agents associated with a preventive effect on Alzheimer's disease: a review of the epidemiologic evidence
about
sameAs
Dexamethasone diminishes the pro-inflammatory and cytotoxic effects of amyloid beta-protein in cerebrovascular smooth muscle cells.Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's diseaseDementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture.Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxiaEpidemiology of schizophrenia: review of findings and mythsDementia prevention: methodological explanations for inconsistent results.Novel flurbiprofen derivatives with improved brain delivery: synthesis, in vitro and in vivo evaluations.Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss: Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy.Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review.Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra.Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid.A review: inflammatory process in Alzheimer's disease, role of cytokines.Association study of polymorphisms in the cyclooxygenase-2 gene and Alzheimer's disease risk in Chinese.
P2860
Q35013183-0CA4C490-DFE3-45AE-B989-DE6B5A6E4901Q35141182-5EF5D831-3E44-4608-A272-AAFC7F44B822Q35394390-736EA157-89FF-4EFA-9746-5D991739A520Q36828651-69DD68DF-4345-47C3-B9CD-6325F9E9D6E4Q36919282-01A884FF-51E1-4C30-B168-EF2A65E8A18BQ37263684-36E3C09C-8735-4C37-AA72-E79EAEF9D332Q38741052-CBCA5BD9-73DA-41A8-949F-F5EE27978486Q39085129-41F56D23-DAF6-436D-849B-D9A232BE523AQ39428788-B24EC637-3B1C-4B4D-8E30-782E45066DF2Q41616792-EA47C9FD-7E0B-48E3-A783-FC12B6B67811Q44823899-166B7B8E-353A-4099-A7BC-97E48458096DQ53328528-4559E526-2F32-465D-BB04-FDD818F1D384Q53328952-044F893A-7509-4F66-92A0-A007DEBE2DFB
P2860
Pharmacologic agents associated with a preventive effect on Alzheimer's disease: a review of the epidemiologic evidence
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pharmacologic agents associate ...... of the epidemiologic evidence
@ast
Pharmacologic agents associate ...... of the epidemiologic evidence
@en
Pharmacologic agents associate ...... of the epidemiologic evidence
@nl
type
label
Pharmacologic agents associate ...... of the epidemiologic evidence
@ast
Pharmacologic agents associate ...... of the epidemiologic evidence
@en
Pharmacologic agents associate ...... of the epidemiologic evidence
@nl
prefLabel
Pharmacologic agents associate ...... of the epidemiologic evidence
@ast
Pharmacologic agents associate ...... of the epidemiologic evidence
@en
Pharmacologic agents associate ...... of the epidemiologic evidence
@nl
P2093
P356
P1476
Pharmacologic agents associate ...... of the epidemiologic evidence
@en
P2093
B A in 't Veld
B H Ch Stricker
L J Launer
M M B Breteler
P304
P356
10.1093/EPIREV/MXF001
P407
P577
2002-01-01T00:00:00Z